Biotech

All Articles

Novo inks $600M NanoVation bargain to study genetic medicines ex-liver

.Novo Nordisk is proceeding its press right into hereditary medications, agreeing to compensate Nano...

Innovent web links cytokine to intestines cancer cells actions

.Innovent Biologics has helped make the instance that its checkpoint inhibitor-cytokine fusion healt...

Merck, Daiichi ADC strikes target in phase 3 bronchi cancer cells research study

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina deepens AI concentrate with collab to pick cancer cells targets

.Five months after Rakovina Rehabs rotated towards artificial intelligence, the cancer-focused biote...

Ascendis' dwarfism medicine smash hits in stage 3, endangers BioMarin

.Ascendis Pharma has actually become a possible danger to BioMarin's Voxzogo, mentioning phase 3 dev...

Despite ph. 3 overlook, Alkeus observes pathway ahead of time for eye condition possession

.Though Alkeus Pharmaceuticals' oral eye illness asset stopped working to dramatically lower geograp...

Kairos goes social along with $6M IPO to finance tests of cancer medicine

.With a trio of biotechs striking the Nasdaq on Friday, it was easy to miss a smaller-scale social l...

Vaccine and Keytruda combo successful in squamous tissue carcinoma

.Immune gate preventions are actually the superheroes of cancer cells therapy. Drugs like Bristol My...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, firings ...

Regeneron's Opdualag competitor reveals 57% feedback rate

.Regeneron is actually back along with lasting consequence for its own LAG-3 inhibitor and PD-1 inhi...